TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 15353498

Group type: EXPERIMENTAL
Intervention: Atorvastatin 80 mg/d
Number of subjects: 2341

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2341
Study: 11444637

Group type: EXPERIMENTAL
Intervention: Monovision (single vision Acuvue lenses)
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Acuvue Bifocal contact lenses
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Contact lens wear
Number of subjects: 150
Study: 9760347

Group type: EXPERIMENTAL
Intervention: Caffeine (6 mg/kg)
Number of subjects: 9

Group type: COMPARATOR
Intervention: Placebo (dextrose)
Number of subjects: 9
Study: 10155673

Group type: EXPERIMENTAL
Intervention: Polychemotherapy (VP: vindesine and cisplatin; CAP: cyclophosphamide, doxorubicin and cisplatin)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Best supportive care
Number of subjects: 70
Study: 2234804

Group type: EXPERIMENTAL
Intervention: Topical dexamethasone drops
Number of subjects: 0

Group type: COMPARATOR
Intervention: Topical flurbiprofen drops
Number of subjects: 0
Study: 355604

Group type: COMPARATOR
Intervention: Best conventional care (no chemotherapy or radiotherapy)
Number of subjects: 303

Group type: EXPERIMENTAL
Intervention: BCNU (80 mg/sq m/day on 3 successive days every 6 to 8 weeks)
Number of subjects: 303

Group type: EXPERIMENTAL
Intervention: Radiotherapy (5000 to 6000 rads to the whole brain)
Number of subjects: 303

Group type: EXPERIMENTAL
Intervention: BCNU plus radiotherapy
Number of subjects: 303
Study: 31814226

Group type: EXPERIMENTAL
Intervention: Malic acid lozenge
Number of subjects: 110

Group type: COMPARATOR
Intervention: Citric acid mouthwash
Number of subjects: 110
Study: 30875425

Group type: EXPERIMENTAL
Intervention: Early Excision and Grafting (EEG)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Delayed Excision and Grafting (DEG)
Number of subjects: 50
Study: 28615354

Group type: EXPERIMENTAL
Intervention: Strong African American Families program
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control condition
Number of subjects: 0
Study: 26092291

Group type: EXPERIMENTAL
Intervention: Secukinumab 300 mg
Number of subjects: 676

Group type: COMPARATOR
Intervention: Ustekinumab
Number of subjects: 676
Study: 23586326

Group type: EXPERIMENTAL
Intervention: Porcelain fused to base metal alloy (BMA)
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Porcelain fused to noble metal alloy (NMA)
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Zirconium oxide-based ceramics
Number of subjects: 23

Group type: COMPARATOR
Intervention: Overall (all groups)
Number of subjects: 23
Study: 21191575

Group type: EXPERIMENTAL
Intervention: Acetaminophen 2 g/day
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Acetaminophen 3 g/day
Number of subjects: 45

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 45
Study: 18489015

Group type: EXPERIMENTAL
Intervention: Bupropion (150 mg)
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: Bupropion (300 mg)
Number of subjects: 33

Group type: COMPARATOR
Intervention: D-amphetamine (20 mg)
Number of subjects: 33

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 33
Study: 16766006

Group type: EXPERIMENTAL
Intervention: Dihydroartemisinin/piperaquine (DHA-PQP)
Number of subjects: 762

Group type: EXPERIMENTAL
Intervention: Amodiaquine+artesunate (AQ+AS)
Number of subjects: 762

Group type: COMPARATOR
Intervention: Amodiaquine+sulfadoxine/pyrimethamine (AQ+SP)
Number of subjects: 762
Study: 14566693

Group type: EXPERIMENTAL
Intervention: Propiverine (15 mg t.i.d.)
Number of subjects: 98

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 98
Study: 10784360

Group type: EXPERIMENTAL
Intervention: Angiotensin II pressor dose (1-3 microg/min)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Angiotensin II subpressor dose (0.0375-0.15 microg/min)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Angiotensin II pressor dose + Losartan (50 mg)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Angiotensin II subpressor dose + Losartan (50 mg)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo (electrolyte solution)
Number of subjects: 60
Study: 1833529

Group type: COMPARATOR
Intervention: Normal saline (control group)
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Meperidine (12.5 mg every 5 minutes up to a maximum of 50 mg)
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Fentanyl (25 micrograms every 5 minutes up to a maximum of 100 micrograms)
Number of subjects: 29
Study: 6972823

Group type: COMPARATOR
Intervention: Medical treatment
Number of subjects: 58

Group type: COMPARATOR
Intervention: Surgical treatment
Number of subjects: 58
Study: 30347634

Group type: EXPERIMENTAL
Intervention: Non-Local Means (NLM) filtering
Number of subjects: 0

Group type: COMPARATOR
Intervention: Distance-Driven MAR (DDMar)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Linear Interpolation-based MAR (LIMar)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Intensity thresholding
Number of subjects: 0
Study: 28956671

Group type: EXPERIMENTAL
Intervention: Raw crushed garlic (100 mg/kg body weight, 2 times a day for 4 weeks)
Number of subjects: 40
Study: 26615605

Group type: EXPERIMENTAL
Intervention: Spironolactone 100 mg/day plus standard ADHF therapy
Number of subjects: 100

Group type: COMPARATOR
Intervention: Standard ADHF therapy alone
Number of subjects: 100
Study: 24233571

Group type: EXPERIMENTAL
Intervention: 11% CP (low CP)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: 13% CP (high CP)
Number of subjects: 24
Study: 22405443

Group type: EXPERIMENTAL
Intervention: Seclusion room
Number of subjects: 105

Group type: COMPARATOR
Intervention: Physical restraints
Number of subjects: 105
Study: 20216020

Group type: EXPERIMENTAL
Intervention: Ultrasound (US) technique for brachial plexus block
Number of subjects: 25

Group type: COMPARATOR
Intervention: Other nerve location methods
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Different US-guided techniques
Number of subjects: 25
Study: 17095117

Group type: EXPERIMENTAL
Intervention: Fluid Replacement Trial (FR-trial) - water bolus (5.0 mL/kg body mass) ingested immediately pre-exercise and every 20 min during exercise (2.0 mL/kg body mass)
Number of subjects: 15

Group type: COMPARATOR
Intervention: No Fluid Ingestion Trial (NF-trial) - no fluid ingested
Number of subjects: 15
Study: 16272801

Group type: EXPERIMENTAL
Intervention: Handgrip exercise training (4 times a week for 6 weeks)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Handgrip exercise training
Number of subjects: 8

Group type: COMPARATOR
Intervention: Healthy controls (no intervention)
Number of subjects: 8
Study: 11864856

Group type: EXPERIMENTAL
Intervention: High-fat evening meal (62% of energy from fat)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Low-fat evening meal (16% of energy from fat)
Number of subjects: 12
Study: 10199771

Group type: EXPERIMENTAL
Intervention: Flutamide (250 mg/day)
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: Finasteride (5 mg/day)
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: Ketoconazole (300 mg/day)
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: Ethinyl estradiol-cyproterone acetate (0.01 mg EE/day for the first week, 0.02 mg EE/day for the second week, 0.01 mg EE/day for the third week, followed by a pause of 7 days, then 12.5 mg CPA/day for the first 10 days of every month for 12 months)
Number of subjects: 66

Group type: COMPARATOR
Intervention: Comparison of EE-CPA and finasteride
Number of subjects: 66

Group type: COMPARATOR
Intervention: Comparison of flutamide and finasteride
Number of subjects: 66

Group type: COMPARATOR
Intervention: Comparison of flutamide and finasteride (hair diameter)
Number of subjects: 66
Study: 7557767

Group type: EXPERIMENTAL
Intervention: Primary closure technique with Penrose drains (test group)
Number of subjects: 52

Group type: COMPARATOR
Intervention: Primary closure technique without Penrose drains (control group)
Number of subjects: 52
Study: 2242455

Group type: EXPERIMENTAL
Intervention: Mastectomy
Number of subjects: 269

Group type: EXPERIMENTAL
Intervention: Lumpectomy (breast conservation surgery)
Number of subjects: 269

Group type: EXPERIMENTAL
Intervention: Surgeons who offered a choice of treatment
Number of subjects: 269

Group type: COMPARATOR
Intervention: Surgeons who favoured mastectomy
Number of subjects: 269

Group type: COMPARATOR
Intervention: Surgeons who favoured breast conservation
Number of subjects: 269
Study: 6183902

Group type: EXPERIMENTAL
Intervention: Methotrexate with leucovorin (100 mg i.v.)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Methotrexate without leucovorin
Number of subjects: 36

Group type: COMPARATOR
Intervention: Four different intermittent dosage schedules of methotrexate
Number of subjects: 36
Study: 30889154

Group type: EXPERIMENTAL
Intervention: 200mg selenium yeast once daily
Number of subjects: 130

Group type: COMPARATOR
Intervention: Placebo tablets once daily
Number of subjects: 130
Study: 29535139

Group type: EXPERIMENTAL
Intervention: Calorie Restriction (CR) group: formula diet containing 60% of the daily energy requirement for 7 days before surgery
Number of subjects: 82

Group type: COMPARATOR
Intervention: Control group: ad libitum food for 7 days before surgery
Number of subjects: 82
Study: 26850135

Group type: EXPERIMENTAL
Intervention: Abdominal closure protocol
Number of subjects: 233

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 233
Study: 24842182

Group type: EXPERIMENTAL
Intervention: Continuous ultrasound-guided adductor canal block with 0.2% ropivacaine
Number of subjects: 80

Group type: COMPARATOR
Intervention: Sham catheter
Number of subjects: 80
Study: 22180577

Group type: EXPERIMENTAL
Intervention: Combination pharmacotherapy (bupropion, nicotine lozenge, nicotine patch, bupropion + lozenge, patch + lozenge)
Number of subjects: 2846

Group type: COMPARATOR
Intervention: Monotherapy
Number of subjects: 2846
Study: 21226430

Group type: EXPERIMENTAL
Intervention: Saline
Number of subjects: 55

Group type: COMPARATOR
Intervention: Air
Number of subjects: 55
Study: 17934827

Group type: EXPERIMENTAL
Intervention: Infliximab
Number of subjects: 198

Group type: EXPERIMENTAL
Intervention: Concurrent immunomodulators
Number of subjects: 198

Group type: EXPERIMENTAL
Intervention: Smoking
Number of subjects: 198
Study: 15901041

Group type: EXPERIMENTAL
Intervention: Sertraline hydrochloride 100 mg tablets (formulation 1)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Sertraline hydrochloride 100 mg tablets (formulation 2)
Number of subjects: 0
Study: 12867212

Group type: EXPERIMENTAL
Intervention: Psychotherapeutic interventions
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Less controlled studies
Number of subjects: 0
Study: 10338414

Group type: EXPERIMENTAL
Intervention: Endotracheal Tube (ETT)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Esophageal‐tracheal Combitube (ETC)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Laryngeal Mask Airway (LMA)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: All devices (ETT, LMA, ETC)
Number of subjects: 12
Study: 8750405

Group type: EXPERIMENTAL
Intervention: Lisinopril (10 to 20 mg/d)
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Bisoprolol (2.5 to 10 mg/d)
Number of subjects: 52
Study: 2027477

Group type: EXPERIMENTAL
Intervention: Phosphatidylserine (100 mg BC‐PS tid)
Number of subjects: 149

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 149
Study: 6487752

Group type: EXPERIMENTAL
Intervention: Controlled release capsule (15 mg)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Standard release tablets (5 mg, t.i.d.)
Number of subjects: 18
Study: 30690250

Group type: EXPERIMENTAL
Intervention: Basic information group
Number of subjects: 383

Group type: EXPERIMENTAL
Intervention: Precautionary group
Number of subjects: 383

Group type: EXPERIMENTAL
Intervention: Personal exposure measurement group
Number of subjects: 383
Study: 29037240

Group type: EXPERIMENTAL
Intervention: KH176 single dose of 800 mg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: KH176 multiple doses of 400 mg b.i.d. for 7 days
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: KH176 single doses of 2000 mg
Number of subjects: 0

Group type: COMPARATOR
Intervention: KH176 lower doses
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: KH176 pharmacokinetics
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: KH176 renal excretion
Number of subjects: 0

Group type: COMPARATOR
Intervention: KH176 effects on redox biomarkers
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: KH176 exposure-response modelling
Number of subjects: 0
Study: 25835119

Group type: EXPERIMENTAL
Intervention: Preoperative one week enteral nutrition (EN)
Number of subjects: 106

Group type: COMPARATOR
Intervention: Early postoperative enteral nutrition (EN)
Number of subjects: 106
Study: 24302596

Group type: EXPERIMENTAL
Intervention: GAD-alum (20 µg)
Number of subjects: 218

Group type: EXPERIMENTAL
Intervention: GAD-alum (2 doses)
Number of subjects: 218

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 218
Study: 22357746

Group type: EXPERIMENTAL
Intervention: Whole-grain wheat (WW)
Number of subjects: 79

Group type: COMPARATOR
Intervention: Refined wheat (RW)
Number of subjects: 79
Study: 19955927

Group type: EXPERIMENTAL
Intervention: Preoperative clinical judgment of residual disease after primary cytoreductive surgery
Number of subjects: 20

Group type: COMPARATOR
Intervention: Prediction models
Number of subjects: 20
Study: 17538634

Group type: EXPERIMENTAL
Intervention: NRP with team training
Number of subjects: 100

Group type: COMPARATOR
Intervention: Standard NRP
Number of subjects: 100
Study: 15166533

Group type: EXPERIMENTAL
Intervention: Loss-frame intervention (negative consequences of unsafe sex)
Number of subjects: 585

Group type: EXPERIMENTAL
Intervention: Gain-frame intervention (positive consequences of safer‐sex)
Number of subjects: 585

Group type: COMPARATOR
Intervention: Attention-control clinics (medication adherence)
Number of subjects: 585
Study: 11157525

Group type: EXPERIMENTAL
Intervention: Nasal diamorphine spray
Number of subjects: 404
Study: 9551683

Group type: EXPERIMENTAL
Intervention: Upright posture
Number of subjects: 9
Study: 7914754

Group type: EXPERIMENTAL
Intervention: Esmolol (1.0 mg/kg bolus followed by 100 micrograms/kg/min continuous infusion)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Saline placebo (equal volume to esmolol)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Esmolol and Saline placebo (both groups)
Number of subjects: 40
Study: 2972542

Group type: EXPERIMENTAL
Intervention: Thrombolysis (intracoronary streptokinase)
Number of subjects: 236

Group type: COMPARATOR
Intervention: Conventional treatment (control group)
Number of subjects: 236
Study: 29996849

Group type: EXPERIMENTAL
Intervention: Artemether-lumefantrine (AL)
Number of subjects: 509

Group type: EXPERIMENTAL
Intervention: Dihydroartemisinin-piperaquine (DP)
Number of subjects: 509
Study: 28098951

Group type: EXPERIMENTAL
Intervention: Web‐based feedback on hazardous drug exposures plus tailored messages to address barriers
Number of subjects: 393

Group type: COMPARATOR
Intervention: Web‐based continuing education video
Number of subjects: 393
Study: 26143313

Group type: EXPERIMENTAL
Intervention: Nebulized morphine 20 mg
Number of subjects: 300

Group type: EXPERIMENTAL
Intervention: Nebulized morphine 10 mg
Number of subjects: 300

Group type: COMPARATOR
Intervention: IV morphine 2 mg
Number of subjects: 300
Study: 23933155

Group type: EXPERIMENTAL
Intervention: MPC2 gene variants (rs10489202 and rs203861)
Number of subjects: 2115
Study: 21205122

Group type: EXPERIMENTAL
Intervention: Linagliptin 5 mg once daily for 24 weeks
Number of subjects: 503
Study: 18457785

Group type: EXPERIMENTAL
Intervention: Minimal intervention (Present and Prevent PowerPoint program, 2 sessions of 30 minutes each)
Number of subjects: 880
Study: 15867849

Group type: EXPERIMENTAL
Intervention: Ciclesonide 40 microg
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Ciclesonide 80 microg
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Ciclesonide 160 microg
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Ciclesonide (all doses)
Number of subjects: 24
Study: 12569144

Group type: EXPERIMENTAL
Intervention: Single-fraction radiotherapy (8 Gy)
Number of subjects: 1157

Group type: COMPARATOR
Intervention: Multiple-fraction radiotherapy (six fractions of 4 Gy each)
Number of subjects: 1157
Study: 10376116

Group type: EXPERIMENTAL
Intervention: Penicillin V (250 mg orally twice daily for 4 months)
Number of subjects: 37

Group type: COMPARATOR
Intervention: Placebo (for 4 months)
Number of subjects: 37
Study: 8829493

Group type: COMPARATOR
Intervention: Colchicine alone (group I)
Number of subjects: 154

Group type: EXPERIMENTAL
Intervention: Colchicine + benzathine penicillin (group II)
Number of subjects: 154

Group type: COMPARATOR
Intervention: Comparison of group I and group II
Number of subjects: 154
Study: 1948722

Group type: EXPERIMENTAL
Intervention: Effective single doses of antianginal drugs
Number of subjects: 62

Group type: COMPARATOR
Intervention: Ineffective doses of nitrates, calcium antagonists and placebo
Number of subjects: 62

Group type: COMPARATOR
Intervention: Ineffective single doses of propranolol
Number of subjects: 62

Group type: COMPARATOR
Intervention: Ineffective single doses of nitrates, calcium antagonists and placebo
Number of subjects: 62
Study: 6520009

Group type: EXPERIMENTAL
Intervention: Experimental group (received a booklet about exercise)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (no exposure to the booklet)
Number of subjects: 0
Study: 30940010

Group type: EXPERIMENTAL
Intervention: Later inquiries
Number of subjects: 10

Group type: COMPARATOR
Intervention: Earlier inquiries
Number of subjects: 10
Study: 29549067

Group type: EXPERIMENTAL
Intervention: Internet-based cognitive behavioral therapy (iCBT) for 14 weeks
Number of subjects: 117
Study: 26865254

Group type: EXPERIMENTAL
Intervention: Task-sharing model of locally delivered mental health care integrated into primary health care (PHC) delivered over 18 months
Number of subjects: 324

Group type: COMPARATOR
Intervention: Established and effective model of specialist mental health care delivered by psychiatric nurses at an out-patient clinic within a centrally located general hospital (active control)
Number of subjects: 324
Study: 23503991

Group type: EXPERIMENTAL
Intervention: CO2 insufflation at low pressure (40-50 mmHg) alternating with fluid medium
Number of subjects: 94

Group type: COMPARATOR
Intervention: Fluid medium for joint distension at pump pressure (50-70 mmHg)
Number of subjects: 94

Group type: COMPARATOR
Intervention: Fluid medium for joint distension
Number of subjects: 94

Group type: EXPERIMENTAL
Intervention: CO2 insufflation
Number of subjects: 94
Study: 22735306

Group type: EXPERIMENTAL
Intervention: Ischemic preconditioning (intermittent arm ischemia through 4 cycles of 5‐minute inflation and 5‐minute deflation of a blood pressure cuff)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Standard care without ischemic preconditioning
Number of subjects: 100
Study: 20847403

Group type: EXPERIMENTAL
Intervention: Aerobic exercise for 6 months
Number of subjects: 28

Group type: COMPARATOR
Intervention: Stretching (control) for 6 months
Number of subjects: 28
Study: 17710005

Group type: EXPERIMENTAL
Intervention: Nimesulide 100 mg b.i.d.
Number of subjects: 94

Group type: COMPARATOR
Intervention: Naproxen 500 mg b.i.d.
Number of subjects: 94

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 94
Study: 12549941

Group type: EXPERIMENTAL
Intervention: Cetirizine
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Fexofenadine
Number of subjects: 18

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18
Study: 10715292

Group type: EXPERIMENTAL
Intervention: Intervention - researcher helped create an agenda, facilitated discussion, and created a record of the consultation in real time
Number of subjects: 24

Group type: COMPARATOR
Intervention: Control - researcher observed the consultation
Number of subjects: 24
Study: 8649228

Group type: EXPERIMENTAL
Intervention: DHA supplementation in infant formula
Number of subjects: 0

Group type: COMPARATOR
Intervention: Breast-fed infants
Number of subjects: 0

Group type: COMPARATOR
Intervention: Formula-fed infants
Number of subjects: 0
Study: 1606995

Group type: EXPERIMENTAL
Intervention: Alprazolam 1 mg alone
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Alprazolam 1 mg combined with alcohol 0.5 g/kg
Number of subjects: 48

Group type: COMPARATOR
Intervention: Placebo capsule and alcohol 0.5 g/kg
Number of subjects: 48

Group type: COMPARATOR
Intervention: Placebo capsule and placebo drink
Number of subjects: 48
Study: 4020207

Group type: EXPERIMENTAL
Intervention: Levamisole (150 mg tablet once every fortnight)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Specific antileprosy treatment (control group)
Number of subjects: 20
Study: 29748192

Group type: EXPERIMENTAL
Intervention: Emotion Regulation (ER) skills training
Number of subjects: 0

Group type: COMPARATOR
Intervention: Time- and attention-matched comparison group
Number of subjects: 0
Study: 27733388

Group type: EXPERIMENTAL
Intervention: 10 mM ketorolac (nonselective COX inhibitor)
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: 10 mM NG‐nitro‐l‐arginine methyl ester (nonselective NOS inhibitor)
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Combination of both inhibitors (COX and NOS)
Number of subjects: 23

Group type: COMPARATOR
Intervention: Vehicle control site (lactated Ringer)
Number of subjects: 23
Study: 25037746

Group type: EXPERIMENTAL
Intervention: Improvement from microalbuminuria to normoalbuminuria after 2 years
Number of subjects: 22984

Group type: COMPARATOR
Intervention: Deterioration from normoalbuminuria to microalbuminuria
Number of subjects: 22984

Group type: COMPARATOR
Intervention: Changes in systolic BP control
Number of subjects: 22984

Group type: COMPARATOR
Intervention: Glucose status
Number of subjects: 22984
Study: 22632585

Group type: EXPERIMENTAL
Intervention: Chiropractic treatment
Number of subjects: 115

Group type: COMPARATOR
Intervention: Self-management
Number of subjects: 115
Study: 20662629

Group type: EXPERIMENTAL
Intervention: Body empowerment intervention (manualized, four-session, peer-led, interactive group intervention)
Number of subjects: 189

Group type: COMPARATOR
Intervention: Control group received HIV Counseling and Testing (HIV-CT) enriched by female condom counseling
Number of subjects: 189
Study: 18394446

Group type: EXPERIMENTAL
Intervention: Unopposed micronized 17beta‐estradiol 1 mg/day
Number of subjects: 180

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 180
Study: 15853097

Group type: EXPERIMENTAL
Intervention: Diafix‐oral (Mueller‐Dental)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: MPS gel (Premier)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: P 403‐W (Dentsply)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Occlubrush (KerrHawe)
Number of subjects: 80